Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease

Background. Fatty liver index (FLI) and lipid accumulation product (LAP) are indexes originally designed to assess the risk of fatty liver and cardiovascular disease, respectively. Both indexes have been proven to be reliable markers of subsequent metabolic syndrome; however, their ability to predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yuan-Lung, Wang, Yuan-Jen, Lan, Keng-Hsin, Huo, Teh-Ia, Huang, Yi-Hsiang, Su, Chien-Wei, Hsieh, Wei-Yao, Hou, Ming-Chih, Lin, Han-Chieh, Lee, Fa-Yauh, Wu, Jaw-Ching, Lee, Shou-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282434/
https://www.ncbi.nlm.nih.gov/pubmed/28194177
http://dx.doi.org/10.1155/2017/9279836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282434/
https://www.ncbi.nlm.nih.gov/pubmed/28194177
http://dx.doi.org/10.1155/2017/9279836

Ejemplares similares